Biocon Biologics gets US nod to launch Stelara biosimilar by India News Online Team December 1, 2024 0 Biocon Biologics, the subsidiary of Biocon on Saturday has received the USFDA nod to launch the biosimilar version of Janssen's Stelara (Ustekinumab) used for the treatment of autoimmune disorders ...